ci report solid head esrx deal compani beat metric
reduc cost trend guidanc meanwhil compani bullish commentari
rais estim unchang po base ep vs
prior estim revis estim alreadi factor better growth
reiter buy rate strong momentum head esrx deal
stand-alone outlook posit esrx upsid
look manag expect attract financi perform organ
growth revenu membership earn ci note expect tailwind
off-set headwind headwind lower exchang margin busi
outperform return normal next year repres million after-tax
headwind forecast prior period develop million headwind
combin would headwind tailwind custom base growth
includ expans relationship specialti product
group disabl life busi growth compani see health insur fee
impact meanwhil acquisit esrx would accret
fischbeck focu section choos theme explor detail either
respons recent investor question unexpect develop
quarter quarter focu potenti ci pf esrx valuat scenario
compani trade discount despit solid growth outlook upsid enhanc
pharmaci benefit manag pbm capabl esrx deal pro
forma expect free cash flow extra oper
contract run-off base case scenario analysi suggest valuat
bull case scenario suggest reiter buy
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
total benefit claim
total invest
oper return averag asset
long term debt cap ratio ex fa
amtz dac pre-tax profit bef amtz dac
one largest provid manag
care servic us origin properti
casualti insur compani found
larg focus healthcar
busi offer hmo indemn product
well meaning intern life
ci core busi continu improv creat
averag earn growth prospect
addit upsid capit deploy
fischbeck focu section choos theme explor detail either
respons recent investor question unexpect develop
quarter quarter focu potenti ci pf esrx valuat scenario
compani trade discount despit solid growth outlook upsid enhanc
pharmaci benefit manag pbm capabl esrx deal pro
forma expect free cash flow extra oper
contract run-off reiter buy
estim earn mix roughli ci/esrx meanwhil
factor increment interest expens associ financ deal
synergi estim compani could pf net incom
synergi assum modest share repo billion debt pay per
year get debt/cap end estim ci pf esrx could pf
ep basic achiev low end compani target
year ahead schedul assum compani build anoth
billion excess cash top current cash need run
pf ni synergi
could stock trade
bear case scenario appli multipl stand-alone ci
discount antm current forward multipl multipl stand-alone esrx
ad extra cash flow leftov share repo debt paydown estim
valuat combin compani around stock trade
blend basi would impli pf multipl
base case scenario appli multipl stand-alone ci
antm current forward multipl multipl stand-alone esrx ad
extra cash flow leftov share repo debt paydown estim valuat
combin compani blend basi would impli pf multipl
bull case scenario appli multipl stand-alone ci unh current
forward multipl multipl stand-alone esrx ad extra cash flow
leftov share repo debt paydown estim valuat
combin compani blend basi would impli pf multipl
price-to-earnings multipl ep
stand-alone esrx multipl
one problem scenario appli stand-alone
esrx multipl pbm earn combin compani perspect
ep conserv multipl use stand-alone mani way
probabl bearish take account fact pbm part
broader organ view combin compani broader suit
servic sell custom better valu proposit market pbm
also influenc medic cost meanwhil time esrx serv ci risk
membership creat sticki earn stream result matter multipl
assum stand-alone pbm would argu pbm insid deserv
premium number case point trade ep highest
multipl diversifi name even though earn pbm
remain bullish ci pf esrx see upsid ep estim like
flexibl enhanc capabl deal think stock could trade
higher multipl deal close compani execut strateg plan
guid rais initi thought
ci rais adjust ep guidanc midpoint impli
ep growth year year similar last quarter guidanc rais
beat versu consensu addit annual consolid
revenu growth outlook rais basi point expect
compani increas consolid adjust incom oper
billion previou guidanc rais driven global
health midpoint group disabl life
midpoint partial off-set decreas global supplement benefit
outlook meanwhil corporate/oth adjust incom oper
govern outlook lower basi point midpoint
approxim driven strong perform busi
commerci expect approxim vs midpoint
previous meanwhil healthcar oper expens ratio expect
consist previou midpoint
compani lower medic cost trend guidanc
previous note compon trend within rang
compani re-affirmed adjust tax rate continu expect
membership growth member
relat manag expect attract financi perform organ
growth revenu membership earn ci note expect tailwind
off-set headwind headwind lower exchang margin busi
outperform return normal next year repres million after-tax
headwind forecast prior period develop million headwind
combin would headwind tailwind custom base growth
includ expans relationship specialti product
group disabl life busi growth compani see health insur fee
tailwind meanwhil acquisit esrx accret
note guidanc exclud impact addit prior period develop
group disabl life
op
op per share
po base ep estim repres premium
five-year averag view appropri given outlook
risk po issu disabl life busi compani see higher
expect cost trend potenti impact futur regulatori chang star
rate continu deterior
kevin fischbeck cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us facil hospit manag healthcar coverag cluster
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
